Cryoport (CYRX) Common Equity (2016 - 2025)
Cryoport (CYRX) has disclosed Common Equity for 15 consecutive years, with $502.6 million as the latest value for Q4 2025.
- Quarterly Common Equity rose 25.07% to $502.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $502.6 million through Dec 2025, up 25.07% year-over-year, with the annual reading at $502.6 million for FY2025, 25.07% up from the prior year.
- Common Equity for Q4 2025 was $502.6 million at Cryoport, down from $513.3 million in the prior quarter.
- The five-year high for Common Equity was $648.0 million in Q2 2021, with the low at $398.8 million in Q1 2025.
- Average Common Equity over 5 years is $531.6 million, with a median of $540.9 million recorded in 2023.
- The sharpest move saw Common Equity skyrocketed 439.19% in 2021, then dropped 26.49% in 2024.
- Over 5 years, Common Equity stood at $641.8 million in 2021, then fell by 13.4% to $555.8 million in 2022, then decreased by 12.02% to $489.0 million in 2023, then decreased by 17.82% to $401.9 million in 2024, then grew by 25.07% to $502.6 million in 2025.
- According to Business Quant data, Common Equity over the past three periods came in at $502.6 million, $513.3 million, and $519.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.